Phase III Clinical Study of Intravenous Administration of S-021812 in Pediatric Patients with Influenza Virus Infection

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220845

Enrollment

100

Registered

2009-09-05

Start date

2009-09-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza virus infection

Interventions

investigational material(s) Generic name etc : S-021812 (Peramivir) INN of investigational material : Therapeutic category code : 625 Anti-virus agents Dosage and Administration for Investigational m

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pediatric patient diagnosed as influenza virus infection

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Efficacy, Safety	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026